tiprankstipranks
Takeda Pharmaceutical Co Ltd (TKPHF)
OTHER OTC:TKPHF
US Market
TKPHF
Takeda Pharmaceutical Co
RESEARCH TOOLSreports

Takeda Pharmaceutical Co (TKPHF) Stock News & Sentiment

36 Followers
Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care
Premium
Company Announcements
Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care
1d ago
Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO
Premium
Company Announcements
Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO
18d ago
Analyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
Premium
Ratings
Analyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
1M ago
TAK
Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1
Premium
Company Announcements
Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1
1M ago
Mamegano Reiterates Buy on Takeda as Q1 Beat and Pipeline Progress Support Unchanged Price Objective
Premium
Ratings
Mamegano Reiterates Buy on Takeda as Q1 Beat and Pipeline Progress Support Unchanged Price Objective
2M ago
TAK
Takeda Delivers Strong Q1 Revenue Growth But Flags Core EPS Decline
Premium
Company Announcements
Takeda Delivers Strong Q1 Revenue Growth But Flags Core EPS Decline
2M ago
Takeda Finalizes Share Issuance for Global Employee Incentive Plan
Premium
Company Announcements
Takeda Finalizes Share Issuance for Global Employee Incentive Plan
2M ago
More TKPHF News >

TKPHF News on the Web

Takeda announces FDA acceptance of zasocitinib under priority review
TipRanks News
Bullish
Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care
TipRanks News
Bullish
Morgan Stanley Remains a Buy on Takeda Pharmaceutical Co (TKPHF)
TipRanks News
Bullish
Protagonist Therapeutics price target raised to $190 from $178 at BMO Capital
TipRanks News
Neutral
Protagonist announces Takeda received U.S. FDA approval for MIMRYLO
TipRanks News
Bullish
Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO
TipRanks News
Bullish
Takeda receives FDA approval of NDA for Mimrylo
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Takeda Pharmaceutical Co (OtherTKPHF)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
TKPHF
Sector Average
Media Buzz
This Week4 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TKPHF’s Media Buzz Sentiment?
4 articles about TKPHF were published this week. In an average week, 3.5 articles are published.
    What is TKPHF’s weekly average amount of articles?
    In an average week, 3.5 articles about TKPHF are published.
      What is TKPHF’s News Sentiment?
      100% of articles about TKPHF were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        BAYRYBayer
        MRKMerck & Company
        TMDXTransMedics Group
        FSPKFFisher & Paykel Healthcare Corporation Limited
        KURAKura Oncology
        Showing the stocks with the most bullish news sentiment over the past week